阿尔茨海默症俗称“AD”,它是一种隐匿性的神经退行性疾病,以认知功能损害和精神行为异常为主要临床表现。AD药物领域市场需求巨大,有数据显示,2023年中国AD药物市场规模约60亿元,预计2030年将突破260亿元,年复合增长率达19%;全球市场规模届时将达314亿美元。在阿尔茨海默症领域,药企纷纷布局。近期,国内药企在AD药物研发领域不断传来积极进展,彰显着攻坚的决心。如11月24日,绿叶制药宣布...
Source Link阿尔茨海默症俗称“AD”,它是一种隐匿性的神经退行性疾病,以认知功能损害和精神行为异常为主要临床表现。AD药物领域市场需求巨大,有数据显示,2023年中国AD药物市场规模约60亿元,预计2030年将突破260亿元,年复合增长率达19%;全球市场规模届时将达314亿美元。在阿尔茨海默症领域,药企纷纷布局。近期,国内药企在AD药物研发领域不断传来积极进展,彰显着攻坚的决心。如11月24日,绿叶制药宣布...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.